In beauty and personal care, and increasingly in food and beverage, the product is rarely made by the company whose name is on it. A contract manufacturer holds the formulation expertise, the certifications, the filling lines and the regulatory dossiers. A brand arrives with a brief, selects from a catalogue of proven bases, adjusts a few actives, chooses a fragrance, and leaves with something that can be on sale in five months.

This is not a scandal and it is not a shortcut. It is how the category is built, and it is the reason a company can launch without owning a factory. But it has a consequence that founders consistently underestimate: the thing they consider their product is the part of the business they control least, and the part a competitor can replicate fastest.

The base is available to anyone who calls the same lab. The percentages are constrained by regulation and by what the formulation will tolerate, so the interesting range is narrow. The ingredient itself cannot be owned — a plant extract, a peptide, an acid at a legal concentration is available to every company in the category and will be marketed by all of them within a season. And in most jurisdictions the full ingredient list is printed on the pack by law, which means the composition is public to any competitor with ten euros and a shelf.

So the product claim has a short life. A company launches on an ingredient. Six months later there are forty products built on the same ingredient, several of them cheaper, at least one of them from a retailer's own label using the same manufacturer. The company responds by raising the percentage, then by adding a second active, then by adding a third, and ends up with a formula that is harder to explain than the one it started with, competing against products that will make the same move next quarter.

What actually differs between two products from the same lab is everything outside the bottle: who the product is for and who it is not for, what the company believes about the category, what it refuses to do, how the range is organised, what the pack communicates in the half-second before the ingredient list is read, and whether any of it is still recognisable in twelve months. None of that comes from the manufacturer, and none of it can be brief-swapped.

This is why two ranges filled on the same line can sit in different price brackets and stay there. The higher one is not better in a laboratory sense. It is more legible: someone can tell you what it stands for without reading the back. That legibility survives the arrival of cheaper copies, because the copy can replicate the formula and cannot replicate the reason for choosing it.

There is a second, quieter consequence. Because the manufacturer is doing the technical work, the company's own capability tends to accumulate in the wrong place. Teams become skilled at sourcing, at cost per unit, at negotiating minimum order quantities and lead times — genuinely valuable skills, and all of them procurement skills. Very few companies build the capability to decide what they are, and that capability does not develop by itself. It shows up as the inability to say no to a line extension, because there is no stated position for the extension to contradict.

The same dynamic now runs through food and beverage. Co-packers make the sauce, the bar, the cold brew, the supplement. A category that looks crowded with distinct offers is often four factories serving eighty brands. Anyone who has walked a private label trade show has seen the unbranded version of half a supermarket aisle sitting on one stand.

The practical question for a company built this way is not how to make the formula more defensible. In most cases it cannot be made defensible, and effort spent there is effort spent competing on the only axis a competitor can match by placing a phone call.

The question is what remains true about the company if the formulation becomes public tomorrow — because it already is. If the answer is a position, a coherent range and an identity a buyer can recognise from across the aisle, the shared manufacturing is irrelevant. If the answer is the formula, then the business is renting its differentiation from a supplier who is also renting it to everyone else, on the same terms, at the same time.